Menu
GeneSAFE™ Inherited / Inherited Risk / screens for 5 common inherited recessive genetic disorders, such as cystic fibrosis, β-thalassemia, companion-cell anemia, deafness - autosomal recessive type 1A, deafness - autosomal recessive type 1B.
GeneSAFE™ De Novo/Age Factor/ screens for 44 severe genetic disorders due to de novo mutations (gene mutation that is not inherited) in 25 genes that cause skeletal dysplasia, congenital heart defects, multiple congenital malformation syndromes, neurodevelopmental disorders such as autism, epilepsy, intellectual disability and sporadic cases of various rare dominant Mendelian disorders such as Schinzel-Gedion syndrome and Bohring-Opitz syndrome. GeneSafe Age Risk is the first non- invasive prenatal test that considers the age of the father as a risk factor, not just that of the mother. As the age of the father increases (over 40-45 years), the risk of having a child with a similar condition due to spontaneous genetic mutations in the male's spermatogenesis rises.
GeneSAFE ™ Complete includes gene testing in the GeneSafe ™ Inherited and GeneSAFE ™ De novo, providing a complete picture of pregnancy risk.
Result within 3 – 7 working days.
Лаборатория EUROFINS Genoma Italy Сертифицирана от Illumina, USA
Consultation with a genetic specialist is included.
It covers the costs of the amniocentesis diagnostic procedure.
By analyzing the cfDNA from the maternal plasma and a sample from the father's oral cavity, it investigates several clinically significant and life-changing genetic disorders that are not detected by the current NIPT technology. The difference from traditional non-invasive prenatal tests that investigate chromosomal aneuploidies such as Trisomy 21 (Down syndrome), Trisomy 18 (Edwards syndrome), Trisomy 18 (Patau syndrome). GeneSafe covers single genes responsible for the development of severe genetic defects in the fetus.
EN 
BG